Central Laboratories Applications & Studies
-
Revitalizing Recruitment In A Lupus Rescue Study
9/11/2025
Recruitment hurdles are overcome by leveraging engaged, data-sharing patient communities. See how a strategic, patient-centric approach delivered a pre-qualified clinical trial cohort quickly and efficiently.
-
Removing Translation Bottlenecks With AI
8/8/2025
See how an AI-enabled approach eliminated the manual, time-consuming translation bottlenecks that often delay clinical trial launches.
-
Flexible Data Management For Growing Portfolio
7/31/2025
Explore strategic enhancements to a small biopharma's biometrics capabilities involving the deployment of 20 specialized professionals, which effectively bolstered the client’s organizational capacity.
-
Analytics–Powered Approach To Patient Recruitment Strategy
7/15/2025
In a Phase 3 psychiatry trial, a pharmaceutical company partnered with Signant to revolutionize patient recruitment through data-driven site selection using PureSignal Analytics.
-
Reframing Clinical Vendor Selection
7/2/2025
Explore a platform that enables seamless vendor selection as well as cross-functional collaboration with built-in templates and tailored question libraries that simplify proposal creation and review.
-
Pioneering Cancer Research Meets Unparalleled Veeva Vault Integration
6/26/2025
A biotech company revolutionizing cancer treatment faced delays due to a complex, error-prone document review process. Discover how integrating an innovative strategy transformed their workflow.
-
RWD's Significance In The Largest FDA-Funded IOL Study Of Pediatric Patients
5/28/2025
With FDA grant support, the American Academy of Ophthalmology and Verana Health conducted the largest real-world study to date on intraocular lens (IOL) use in pediatric cataract patients.
-
Understanding Real-World Patient Characterization And Safety Outcomes Of DEXTENZA
5/8/2025
In this study, we can derive confirmation of DEXTENZA’s favorable safety profile across a broader surgical spectrum.
-
Feasibility Insights In HR+/HER2 - Metastatic Breast Cancer
4/16/2025
This case study showcases how advanced analytics were used to streamline feasibility planning for a Phase II clinical trial targeting HR+/HER2- metastatic breast cancer as a second-line treatment.
-
Timely Lab Data To Inform Outreach To Healthcare Professionals
4/3/2025
Learn how you can leverage a system that offers flexible data delivery formats and seamless integration into commercialization workflows while also ensuring HIPAA-compliant deidentified data for patient privacy.